Concepedia

Daniel S. Mytelka

DS

8

Publications

341

Citations

8

H-Index

1996

Active since

Affiliations

Eli Lilly (United States)(Current)

University of California, Berkeley

Daniel S. Mytelka is an author at Eli Lilly (United States) specializing in medicine, molecular biology, and natural sciences.

ORCID

Top concepts

Publications per year

1996–2019

8

Publications

8

Escherichia coli fliAZY operon

Daniel S. Mytelka, Michael J. Chamberlin · Journal of Bacteriology · 1996 · 68 citations · Full text

, , +13

Analysis and Suppression of DNA Polymerase Pauses Associated with a Trinucleotide Consensus

Daniel S. Mytelka, Michael J. Chamberlin · Nucleic Acids Research · 1996 · 61 citations · Full text

, , +17

Chemotherapy treatment patterns, costs, and outcomes of patients with gastric cancer in the United States: a retrospective analysis of electronic medical record (EMR) and administrative claims data

Lisa M. Hess, Diane Michael, Daniel S. Mytelka et al. · Gastric Cancer · 2015 · 57 citations · Full text

Post‐diagnosis weight loss as a prognostic factor in non‐small cell lung cancer

Daniel S. Mytelka, Li Li, Karin Benoit · Journal of Cachexia Sarcopenia and Muscle · 2017 · 54 citations · Full text

Treatment Patterns and Survival among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and France

Saurabh Nagar, Daniel S. Mytelka, Sean D. Candrilli et al. · Sarcoma · 2018 · 48 citations · Full text

Rows per page

1–5 of 8